Gene: ASXL3
Official Full Name: ASXL transcriptional regulator 3provided by HGNC
Gene Summary: This gene encodes a protein containing a plant homeodomain (PHD) zinc finger domain that plays a role in the regulation of gene transcription. The encoded protein has been shown to negatively regulate lipogenesis by binding to and inhibiting the transcriptional activity of two nuclear hormone receptors, oxysterols receptor LXR-alpha (LXRalpha) and thyroid hormone receptor beta (TRbeta). The encoded protein may also inhibit histone deubiquitination. Mutations in this gene have been identified in human patients with Bainbridge-Ropers syndrome, which is characterized by feeding difficulties, developmental delay and other features. [provided by RefSeq, May 2017]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA00741 | ASXL3 Knockout cell line (293T) | Human | ASXL3 | 1:3~1:6 | negative | Online Inquiry |
| KOA06848 | ASXL3 Knockout cell line (AC16) | Human | ASXL3 | 1:3-1:4 | negative | Online Inquiry |
| KOA22292 | ASXL3 Knockout cell line (BEAS-2B) | Human | ASXL3 | 1:3~1:4 | negative | Online Inquiry |
| KOA37738 | ASXL3 Knockout cell line (U-2932) | Human | ASXL3 | 1:2-1:4 | negative | Online Inquiry |
| KOA53139 | ASXL3 Knockout cell line (TPC-1) | Human | ASXL3 | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.